🔒 IFPMA whitepaper: How assessment reports enable regulatory reliance in pharma
Regulatory reliance helps NRAs avoid duplicative reviews and allocate resources more efficiently by leveraging prior scientific evaluations …
High impact 12 min
Drug profile · INN
clobazam
CLOBAZAM
clobazam (CLOBAZAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 4
Pipeline programs 26
News articles 0
Drug details — clobazam
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 4
- Programs
- 26
- Data quality
- 0.89
Quick answer
clobazam (CLOBAZAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN clobazam
Brand CLOBAZAM
Mechanism GABA-A receptor; anion channel positive allosteric modulator
Target GABA-A receptor; anion channel
Route ORAL
Formulation FILM
Originator Amneal Pharma Europe Ltd
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12428432
Thienopyrimidine derivatives having stereo configurations and use thereof in medicine
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12290597
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 11541002
Oral film compositions and dosage forms having precise active dissolution profiles
granted
Related research
🔒 
🔒 ICH Technology Platform Report: Secure Collaboration Requirements for Regulatory Harmonisation
A single cloud-based platform hosted in Switzerland would enable secure, temporary sharing of commercially confidential information between …
Critical impact 60 min
Frequently asked questions
What is clobazam?
clobazam (CLOBAZAM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clobazam?
CLOBAZAM is a marketed brand name for clobazam. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clobazam?
clobazam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.